Back to Selection     Print       Date : 31 Mar 2025
Fund Summary
Kotak India EQ Contra Fund (G)
[Equity: Contra]  
 
Fund Details
Fund Type Growth Launch Date 27-Jul-2005
Corpus(Cr.) 3935.0 Latest NAV 146.024 As on 30-05-2025
Equity(%) 97.79 52 Week High 158.681
Debt(%) 2.21 52 Week Low 127.901
Others(%) 0.0 Exit Load 1% for redemption within 90 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.88
Scheme Benchmark NIFTY 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Shibani Sircar Kurian
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme aims to generate capital appreciation from a diversified portfolio of equity and equity related instruments. It will invest in stocks of companies, which are fundamentally sound but are undervalued.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 22.87%
Top 10 Holdings 35.53%
Top 25 Holdings 63.29%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 25.21
Software & Services 10.94
Finance & Investments 6.61
Retail 5.72
Pharma & Biotech 4.59
Construction 4.58
Automobile 4.48
Consumer Durables 3.89
Petroleum Products 3.61
Healthcare 3.5
Energy 3.06
Telecom 2.96
Oil & GAS 2.82
Aerospace & Defence 2.52
FMCG 2.3
Cash 2.21
Fertilisers 2.12
Industrial Products 1.68
Transportation 1.6
Food Beverage & Tobacco 1.46
Chemicals 1.28
SERVICES 1.2
Electricals 1.0
Ferrous Metals 0.66
 
 
 
 
 
Portfolio Metrics
PB Ratio 3.25
PE Ratio 20.65
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 6.52
ICICI Bank Limited 6.10
State Bank of India 3.68
Infosys Limited 3.61
Bharti Airtel Limited 2.96
Tech Mahindra Limited 2.71
MphasiS Limited 2.67
Axis Bank Limited 2.45
Reliance Industries Limited 2.44
Triparty Repo 2.39
UltraTech Cement Limited 2.37
Maruti Suzuki India Limited 2.34
Shriram Finance Limited 2.21
Coromandel International Limited 2.12
NTPC Limited 2.06
POWER FINANCE CORPORATION LTD 1.85
GAIL ( INDIA ) LTD 1.82
SWIGGY LIMITED 1.75
Sun Pharmaceutical Industries Limited 1.74
Poonawalla Fincorp Limited 1.73
Inter Globe Aviation Ltd 1.60
Hero MotoCorp Limited 1.59
INDIAN BANK 1.57
Fortis Health Care Ltd 1.55
Radico Khaitan Limited 1.46

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
4.16% 14.17% -1.91% 6.96%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.92% 12.13% 3.05% 11.08%
 
Scheme Benchmark [BSE 500 TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
25.95% 22.94% 27.19% 15.05%
 
 
16.89% 15.56% 22.29% 12.73%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Kotak India EQ Contra Fund (G) 14.87% 0.1838 11.9821% 45.8728 0.0579
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Kotak India EQ Contra Fund (G) 3.3752% 0.9609 0.0313 4.7856 1.0816
 
Back to Selection